Benefit of abemaciclib plus fulvestrant after progression on a CDK4/6 inhibitor Presented ByProf. Kevin Kalinsky, Emory School of Medicine, GA, USA TrialpostMONARCH ConferenceASCO 2024 TypePeer-reviewed article 18 July 2024 15:02